Cargando…
Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges
Cancer is one of the main causes of death worldwide. To date, and despite the advances in conventional treatment options, therapy in cancer is still far from optimal due to the non-specific systemic biodistribution of antitumor agents. The inadequate drug concentrations at the tumor site led to an i...
Autores principales: | Rodríguez, Francisco, Caruana, Pablo, De la Fuente, Noa, Español, Pía, Gámez, María, Balart, Josep, Llurba, Elisa, Rovira, Ramón, Ruiz, Raúl, Martín-Lorente, Cristina, Corchero, José Luis, Céspedes, María Virtudes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9221343/ https://www.ncbi.nlm.nih.gov/pubmed/35740909 http://dx.doi.org/10.3390/biom12060784 |
Ejemplares similares
-
Neural plasticity of the uterus: New targets for endometrial
cancer?
por: Español, Pia, et al.
Publicado: (2022) -
Escherichia coli as a New Platform for the Fast Production of Vault-like Nanoparticles: An Optimized Protocol
por: Fernández, Roger, et al.
Publicado: (2022) -
Intracellular CXCR4(+) cell targeting with T22-empowered protein-only nanoparticles
por: Unzueta, Ugutz, et al.
Publicado: (2012) -
A Comprehensive Map of FDA-Approved Pharmaceutical Products
por: Zhong, Hao, et al.
Publicado: (2018) -
Laparoscopic approach for symptomatic pelvic and para-aortic lymphoceles
por: Aznar, Ana Luzarraga, et al.
Publicado: (2022)